Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of IMS Health Inc. - RX
Business Wire
Nov 05, 2009
Levi & Korsinsky is investigating the Board of Directors of IMS Health
Inc. (“IMS” or the “Company”) (NYSE: RX) for possible breaches of
fiduciary duty and other violations of state law in connection with
their attempt to sell the Company to private equity firm TPG and the CPP
Investment Board of Toronto ("CPP"). Under the terms of the agreement,
IMS shareholders will receive $22 in cash for each IMS share they own
for a total transaction value of approximately $4 billion, including the
assumption of debt.
The investigation concerns whether the IMS Board of Directors have
breached their fiduciary duties to stockholders by failing to adequately
shop the Company before entering into this transaction and whether TPG
and CPP are underpaying for IMS shares, thus unlawfully harming IMS
stockholders.
If you own common stock in IMS and wish to obtain additional
information, please contact us at the number listed below or visit http://www.zlk.com/ims1.html.
Levi & Korsinsky has expertise in prosecuting investor securities
litigation and extensive experience in actions involving financial fraud
and represents investors throughout the nation, concentrating its
practice in securities and shareholder litigation.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
